Literature DB >> 15296640

Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format.

Antje Pommereau1, Everard Pap, Aimo Kannt.   

Abstract

In this study, the authors have compared the performance of 2 high-throughput screening assays for a serin/threonine kinase: a microplate-based, bioluminescent assay that uses the luciferin/luciferase system to monitor ATP consumption, and a microfluidic assay that measures the change in mobility in an electric field of a fluorescently labeled peptide upon phosphorylation. Both assays are homogeneous, nonradioactive, antibody independent and could be miniaturized to a reaction volume of 4 microl. The robustness of both formats was demonstrated by Z' values > 0.8. Screening of a small library (2133 compounds) showed that the results obtained with both technologies correlate very well. Although the threshold for hits was set to a comparably low value-22.2% and 13.7% inhibition for the ATP consumption and microfluidic assay, respectively, corresponding to mean plus 3 standard deviations-the overlap of active compounds identified with the 2 assay formats was greater than 94%. Thus, both assays allow the identification of even low potency inhibitors with a high level of confidence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296640     DOI: 10.1177/1087057104264175

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Jing Liu; Chao Yang; Catherine Simpson; Deborah Deryckere; Amy Van Deusen; Michael J Miley; Dmitri Kireev; Jacqueline Norris-Drouin; Susan Sather; Debra Hunter; Victoria K Korboukh; Hari S Patel; William P Janzen; Mischa Machius; Gary L Johnson; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  ACS Med Chem Lett       Date:  2012-02-09       Impact factor: 4.345

2.  Discovery of Mer kinase inhibitors by virtual screening using Structural Protein-Ligand Interaction Fingerprints.

Authors:  C Da; M Stashko; C Jayakody; X Wang; W Janzen; S Frye; D Kireev
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

3.  Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors.

Authors:  Andrew L McIver; Weihe Zhang; Qingyang Liu; Xinpeng Jiang; Michael A Stashko; James Nichols; Michael J Miley; Jacqueline Norris-Drouin; Mischa Machius; Deborah DeRyckere; Edgar Wood; Douglas K Graham; H Shelton Earp; Dmitri Kireev; Stephen V Frye; Xiaodong Wang
Journal:  ChemMedChem       Date:  2017-01-09       Impact factor: 3.466

4.  Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors.

Authors:  Xiaodong Wang; Jing Liu; Weihe Zhang; Michael A Stashko; James Nichols; Michael J Miley; Jacqueline Norris-Drouin; Zhilong Chen; Mischa Machius; Deborah DeRyckere; Edgar Wood; Douglas K Graham; H Shelton Earp; Dmitri Kireev; Stephen V Frye
Journal:  ACS Med Chem Lett       Date:  2016-09-13       Impact factor: 4.345

5.  Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.

Authors:  Weihe Zhang; Andrew L McIver; Michael A Stashko; Deborah DeRyckere; Brian R Branchford; Debra Hunter; Dmitri Kireev; Michael J Miley; Jacqueline Norris-Drouin; Wendy M Stewart; Minjung Lee; Susan Sather; Yingqiu Zhou; Jorge A Di Paola; Mischa Machius; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

6.  Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.

Authors:  Weihe Zhang; Dehui Zhang; Michael A Stashko; Deborah DeRyckere; Debra Hunter; Dmitri Kireev; Michael J Miley; Christopher Cummings; Minjung Lee; Jacqueline Norris-Drouin; Wendy M Stewart; Susan Sather; Yingqiu Zhou; Gregory Kirkpatrick; Mischa Machius; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

7.  Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP.

Authors:  Meng Jing; Raffaello Verardi; Gianluigi Veglia; Michael T Bowser
Journal:  Anal Methods       Date:  2014-03-07       Impact factor: 2.896

8.  UNC1062, a new and potent Mer inhibitor.

Authors:  Jing Liu; Weihe Zhang; Michael A Stashko; Deborah Deryckere; Christopher T Cummings; Debra Hunter; Chao Yang; Chatura N Jayakody; Nancy Cheng; Catherine Simpson; Jacqueline Norris-Drouin; Susan Sather; Dmitri Kireev; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  Eur J Med Chem       Date:  2013-04-02       Impact factor: 6.514

9.  Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18.

Authors:  Catherine Simpson; Nathaniel G Jones; Emily A Hull-Ryde; Dmitri Kireev; Michael Stashko; Keliang Tang; Jim Janetka; Scott A Wildman; William J Zuercher; Matthieu Schapira; Raymond Hui; William Janzen; L David Sibley
Journal:  ACS Infect Dis       Date:  2015-12-28       Impact factor: 5.084

10.  Efficient solution-phase synthesis of 4,5,7-trisubstituted pyrrolo[3,2-d]pyrimidines.

Authors:  Weihe Zhang; Jing Liu; Michael A Stashko; Xiaodong Wang
Journal:  ACS Comb Sci       Date:  2012-12-05       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.